Back to Results
First PageMeta Content
Health / Acute myeloid leukemia / Myelodysplastic syndrome / Leukemia / Eisai / Clinical trial / Medicine / Acute leukemia / Myeloid leukemia


July 20, 2012 DACOGEN(R) Receives a Positive Regulatory Recommendation in the European Union for Treatment of Acute Myeloid Leukemia DUBLIN, Calif., July 20, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:
Add to Reading List

Open Document

File Size: 16,83 KB

Share Result on Facebook

City

DUBLIN / /

Company

Eisai Inc. / Astex Pharmaceuticals Inc. / Janssen-Cilag International NV / Astex Pharmaceuticals Astex Pharmaceuticals / Astex Pharmaceuticals / /

Continent

Europe / /

Country

Turkey / Russia / United States / Brazil / Canada / Korea / China / Mexico / India / /

Event

FDA Phase / /

IndustryTerm

Treatment of Acute Myeloid Leukemia / pharmaceutical / /

MedicalCondition

Acute Myeloid Leukemia Acute myeloid leukemia / cancer / disease / secondary acute myeloid leukemia / Acute Myeloid Leukemia DUBLIN / myelodysplastic syndromes / shortness of breath / fever / tiredness / infections / /

MedicalTreatment

chemotherapy / intravenous infusion / /

Organization

World Health Organization / European Medicines Agency / European Commission / Committee for Medical Products for Human Use / European Union / /

Person

James S.J. Manuso / /

Position

chairman and chief executive officer / physician / /

Product

cytarabine / DACOGEN / /

ProvinceOrState

California / /

PublishedMedium

the Journal of Clinical Oncology / /

Technology

chemotherapy / /

URL

http /

SocialTag